A team of researchers at the Korea Research Institute of Bioscience and Biotechnology Research (KRIBB) has developed a biosensor capable of monitoring serotonin levels in real-time for diagnosing depression.Depression has been linked to the imbalance of neurotransmitters in the body, genetic predisp
Samsung Bioepis and Organon said Wednesday that the U.S. Food and Drug Administration had approved their citrate-free high-concentration (100 mg/mL) formulation of Hadlima (Ingredient: adalimumab-bwwd), a biosimilar of Humira.The FDA approved the citrate-free high-concentration version of Hadlima ba
Binex said Tuesday it has signed a contract development manufacturing organization (CDMO) agreement with the Seoul National University Hospital (SNUH) to jointly conduct the latter’s research-driven hospital project to develop a new drug candidate RS22802.The company expects to develop it into anti-
Bill Gates, the founder of Microsoft and co-chairman of the Bill & Melinda Gates Foundation, emphasized the importance of international cooperation in responding to infectious diseases like Covid-19 in his address at the National Assembly Tuesday.Gates is visiting the country to sign a memorandum of
CSL, a global bioengineering company, said the company would integrate its subsidiaries into one corporate family under the global CSL brand."As a goal-oriented organization, CSL has demonstrated excellent leadership in biotechnology for more than a century. It is the right time to develop sustainab
Biosensor company i-SENS signed a memorandum of understanding with Meraki Place, a digital healthcare provider, to develop a chronic disease management service on Wednesday.Meraki Place runs a non-face-to-face medical treatment platform, My Doctor, and provides a one-stop service from treatment and
Local researchers have developed and proved the accuracy of a technology that can decipher the eyelid’s meibomian gland image using artificial intelligence.In the past, ophthalmologists measured meiboscore in degrees, a subjective reading method that lacks accuracy and reproducibility.Breaking away
Researchers at the Korea Research Institute of Biotechnology and Bioscience (KRIBB) have developed an ultra-small genetic scissor technology that significantly improved calibration efficiency.Genetic scissors technology removes, inserts, or replaces DNA from a specific base sequence in genes, as rep
T&R Biofab said Wednesday that it signed a strategic joint development agreement with Johnson & Johnson Innovation to develop the 3D bio-printing scaffold technology.According to T&R Biofab, the contract’s purpose is to develop an implantable product in the body based on diverse biomaterials and bio
MiCo BioMed, an in-vitro diagnostic medical device maker, said Tuesday that it completed the clinical trial of the monkeypox testing kit and applied for its export approval to the Ministry of Food and Drug Safety (MFDS).In July, the company conducted a clinical trial of a monkeypox PCR testing kit (
The Korea Health Industry Development Institute (KHIDI) said on Tuesday that it would hold the "2022 Seoul Biomedical International Conference (2022 SIBC)" on Sept. 29 at the Seoul Metropolitan Government’s new office.City Hall hosts and the state agency organizes the sixth annual conference.The con
The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high value-added technologies.In an interview with Korea Biome
KT, the second-largest telco in Korea, has been accelerating its entry into the digital healthcare sector recently. Now, the company is seeking to expand its influence to lead the local healthcare ecosystem.“The healthcare industry is expanding from diagnosis and treatment to prevention and manageme
Huinno, a digital healthcare firm, said Friday the Ministry of Food and Drug Safety (MFDS) chose the company to provide technical support for a national project to adopt the international standards on the quality control of the latest medical devices.The project is jointly organized by Seoul Nationa
Celltrion Healthcare said it has officially begun preparing to directly market its drugs in the U.S. by acquiring Celltrion USA from Celltrion.Celltrion Healthcare and Celltrion believe the acquisition will help maximize profits for both companies by strengthening each company's core competency and
Professor Virginijus Siksnys of the Institute of Biotechnology at Vilinus University opened the third and final day of Bio-Interplex (BIX) Korea 2022 with the keynote speech on the past, present and future of CRISPR-Cas technology on Friday at COEX, southern Seoul.CRISPR technology gained widespread
On the opening day of Bioplus-Interphex (BIX) Korea 2022 on Wednesday, Korea Biomedical Review (KBR) spoke to a variety of foreign companies to discover their intentions for attending the event this year.At the forefront of discussions was healthcare digitalization.Merck gave an engaging presentatio
Bioplus-Interphex Korea 2022, a bio-pharmaceutical exhibition and conference, opened on Wednesday with the Korean government vowing to give full support to the private sector that invests in the biotech industry.The event, co-organized by Korea Biotech Industry Organization (KoreaBIO) and Interphex,
Genencell said Tuesday it obtained approval from Drugs Controller General of India (DCGI) to conduct phase 2/3 trial of ES16001 (pipeline name: GNC102), an oral Covid-19 treatment candidate.The biotech firm is conducting Covid-19 drug trials in multiple countries.In October, it received the nod to c
The Korea Atomic Energy Research Institute (KAERI) said Monday that its Advanced Radiation Technology Institute has developed a precision prediction model for radiation’s damage to DNA for the first time.By precisely predicting the level of radiation’s damage on DNA, medical professionals can evalua
